World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 17 May 2021
Main ID:  ISRCTN95525805
Date of registration: 22/01/2016
Prospective Registration: No
Primary sponsor: James Cook University Hospital
Public title: A cohort study to investigate whether radiolabelled lung nodule localisation and excision is a technically successful and reliable method for excision, in patients with small lung nodule.
Scientific title: A cohort study to investigate whether radiolabelled lung nodule localisation and excision is a technically successful and reliable method for excision, in patients with small lung nodule: a observational, prospective, pilot study
Date of first enrolment: 02/11/2015
Target sample size: 20
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN95525805
Study type:  Observational
Study design:  Observational, prospective, pilot study (Diagnostic)  
Phase:  Not Applicable
Countries of recruitment
United Kingdom
Contacts
Name: Joel    Dunning
Address:  Department of Cardiothoracic Surgery James Cook University Hospital Marton Road TS4 3BW Middlesbrough United Kingdom
Telephone: 01642 850850
Email: joedunning@nhs.net
Affiliation: 
Name: Pankaj Kumar    Mishra
Address:  Department of Cardiothoracic Surgery James Cook University Hospital Marton Road TS4 3BW Middlesbrough United Kingdom
Telephone: 01642 850850
Email: mishrapk_25@yahoo.com
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria:
1. Patients more than 16 years of age
2. Nodules less than 15 mm in size
3. Perceived difficulty in localising and excision of the nodule during surgery

Exclusion criteria:
1. Patients less than 16 years of age
2. Ability to remove mass without radiolabelling
3. Anatomic location of nodule makes it technically difficult to CT guided radiolabelling
4. Patient not willing to undergo the procedure
5. Inability to consent to the operation
6. Pregnancy


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Lung cancer or lung nodules of indeterminate origin
Cancer
Lung cancer
Intervention(s)

Patients with very small nodules not amenable to excision via VATS surgery will be offered the option of radionucleotide injection of their nodules with VATS resection performed on the same day as an alternative to thoracotomy.

Patients will be identified from lung cancer multi-disciplinary (MDT) meetings. These MDT meetings are already an integral part of the researchers thoracic surgery services. They meet these patients to discuss their options for the management of these lung nodules and convey them the decision of the MDT. Patient makes a choice and an informed consent is taken. This new treatment option will be discussed as part of their treatment options.

The procedure will entail an admission to hospital (as per routine practice for patients who are due to undergo surgery). All patients will sign an informed consent form. They will have an injection of radio labelled substance under local anaesthesia by a consultant radiologist in the CT scan room. This is the same technique which is employed for CT guided lung biopsies which is a well-established procedure and the radiology team are well experienced in its conduct.

After this procedure the patient will return to the ward and later that day they will come to theatres, have a general anaesthetic and undergo a minimally invasive excision (key hole surgery) of the nodule in question.

The researchers will use the same key hole surgical technique that they routinely employ for larger nodules excision which they are able to see and feel, but the difference will be that they will use intraoperative gamma probe to detect the exact location of the nodule within the lung tissues. The recovery period from this operation will be about 2-4
Primary Outcome(s)
Technical success of lung nodule excision., assessed via histological confirmation of complete excision of nodule
Secondary Outcome(s)

1. Postoperative complications
2. Length of hospital stay
3. Conversion to Thoracotomy
Secondary ID(s)
Lung Nodule Study Protocol : Version 1.1, 26th Feb 2015
Source(s) of Monetary Support
James Cook University Hospital (UK)
Secondary Sponsor(s)
Ethics review
Status:
Approval date:
Contact:
NRES Committee North West - Lancaster, 27/05/2015, ref: 15/NW/0369
Results
Results available: Yes
Date Posted:
Date Completed: 02/02/2017
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history